{
  "pmcid": "11422119",
  "sha256": "3b371b117162289f2bfe0400f50b30a821e447fac15f07c95aad0383acea2199",
  "timestamp_utc": "2025-11-09T23:16:04.286120+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.397766552408445,
    "reading_ease": 10.500810030669328,
    "word_count": 241
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Intraoperative End-Tidal Carbon Dioxide and Recurrence-Free Survival in Pancreatic Cancer Surgery: A Retrospective Cohort Study"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "This single-center, retrospective cohort study included 652 patients who underwent elective pancreatic cancer resection at Heidelberg University Hospital between 2009 and 2016."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were categorized into high-EtCO2 and low-EtCO2 groups based on mean intraoperative EtCO2 values."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to explore the relationship between EtCO2 levels and recurrence-free survival in pancreatic cancer surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was recurrence-free survival, with secondary outcomes including cardiovascular events, surgical site infections, sepsis, reoperations, and overall survival."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "This single-center, retrospective cohort study included 652 patients who underwent elective pancreatic cancer resection at Heidelberg University Hospital between 2009 and 2016."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "There was no significant difference in recurrence-free survival between the high and low EtCO2 groups [HR = 1.043 (95% CI: 0.875â€“1.243), p = 0.909]."
      },
      "Harms": {
        "score": 1,
        "evidence": "secondary outcomes including cardiovascular events, surgical site infections, sepsis, reoperations, and overall survival."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not applicable."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}